AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Betamethasone; Tolnaftate; Gentamicin; Clioquinol

11 registrations across 1 African market— 11 active

Markets with Betamethasone; Tolnaftate; Gentamicin; Clioquinol

Recent registrations

Brand / ProductMarketHolderStatusExpires
G-Derm Cream
Cream
🇳🇬NigeriaGreenlife Pharmaceutical LimitedactiveMar 2030
Fexotop Cream 30 g (strength format)
Cream
🇳🇬NigeriaFexona Pharmaceuticals Co LtdactiveJan 2029
Quvate Cream (strength format)
Cream
🇳🇬NigeriaVENCHURA PHARMACEUTICALS LIMITEDactiveNov 2028
Funtag Lotion (strength format)
Lotion
🇳🇬NigeriaGreenlife Pharmaceutical LimitedactiveAug 2028
Neutroderm Cream** (
Cream
🇳🇬NigeriaVinco Pharmaceuticals Nigeria LimitedactiveJul 2028
Visiderm Cream (strength format)
Cream
🇳🇬NigeriaElbe Pharma Nigeria LimitedactiveApr 2028
Fungiban Cream
Cream
🇳🇬NigeriaNCI PharmChem Industries LimitedactiveApr 2028
Epiderm Lotion
Lotion
🇳🇬NigeriaShalina Healthcare Nigeria LimitedactiveOct 2026
Epiderm Cream
Cream
🇳🇬NigeriaShalina Healthcare Nigeria LimitedactiveMay 2026
Dermacol Cream (strength format, check composition)
Cream
🇳🇬NigeriaGreenlife Pharmaceutical LimitedactiveMay 2026
Quadriclear Cream
Cream
🇳🇬NigeriaLyn-Edge Pharmaceuticals LimitedactiveDec 2025

Betamethasone; Tolnaftate; Gentamicin; Clioquinol in Africa — Regulatory Overview

Betamethasone; Tolnaftate; Gentamicin; Clioquinol is registered across 1 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Nigeria. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 11 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.